Smith, Edward C
Duke University · Duke Medical Center
2 papers on CoChatORCID 0000-0003-0073-9377
Most cited papers
- Verified
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
Day, J. W., Finkel, R. S., Chiriboga, C. A., Connolly, A. M., Crawford, T. O., Darras, B. T., Iannaccone, S. T., Kuntz, N. L., Peña, L. D. M., Shieh, P. B., et al. (2021) · The Lancet Neurology
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 494
- Verified
Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease
Koeberl, D. D., Case, L. E., Smith, E. C., Walters, C., Han, S.-O., Li, Y., Chen, W., Hornik, C. P., Huffman, K. M., Kraus, W. E., et al. (2018) · Molecular Therapy
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 33
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free